全文获取类型
收费全文 | 7594篇 |
免费 | 557篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 310篇 |
妇产科学 | 122篇 |
基础医学 | 928篇 |
口腔科学 | 89篇 |
临床医学 | 723篇 |
内科学 | 1616篇 |
皮肤病学 | 103篇 |
神经病学 | 810篇 |
特种医学 | 349篇 |
外科学 | 1217篇 |
综合类 | 35篇 |
预防医学 | 529篇 |
眼科学 | 116篇 |
药学 | 569篇 |
中国医学 | 14篇 |
肿瘤学 | 627篇 |
出版年
2024年 | 9篇 |
2023年 | 92篇 |
2022年 | 108篇 |
2021年 | 199篇 |
2020年 | 168篇 |
2019年 | 211篇 |
2018年 | 259篇 |
2017年 | 232篇 |
2016年 | 215篇 |
2015年 | 257篇 |
2014年 | 328篇 |
2013年 | 426篇 |
2012年 | 606篇 |
2011年 | 620篇 |
2010年 | 315篇 |
2009年 | 287篇 |
2008年 | 485篇 |
2007年 | 496篇 |
2006年 | 504篇 |
2005年 | 412篇 |
2004年 | 407篇 |
2003年 | 373篇 |
2002年 | 368篇 |
2001年 | 55篇 |
2000年 | 37篇 |
1999年 | 59篇 |
1998年 | 71篇 |
1997年 | 57篇 |
1996年 | 56篇 |
1995年 | 50篇 |
1994年 | 40篇 |
1993年 | 44篇 |
1992年 | 26篇 |
1991年 | 24篇 |
1990年 | 19篇 |
1989年 | 22篇 |
1988年 | 16篇 |
1987年 | 19篇 |
1986年 | 21篇 |
1985年 | 19篇 |
1984年 | 13篇 |
1983年 | 31篇 |
1982年 | 18篇 |
1981年 | 21篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1975年 | 10篇 |
1967年 | 7篇 |
排序方式: 共有8202条查询结果,搜索用时 31 毫秒
991.
Hiepe F Dörner T Hauser AE Hoyer BF Mei H Radbruch A 《Nature reviews. Rheumatology》2011,7(3):170-178
Aberrant production of autoantibodies by inappropriately self-reactive plasma cells is an inherent characteristic of autoimmune diseases. Several therapeutic strategies aim to deplete the plasma cell pool, or to prevent maturation of B cells into plasma cells. However, accepted views of B-cell biology are changing; recent findings show that long-lived plasma cells refractory to immunosuppressants and B-cell depletion therapies contribute to the maintenance of humoral memory and, in autoimmunity, to autoreactive memory. As a consequence of their longevity and persistence, long-lived plasma cells can support chronic inflammatory processes in autoimmune diseases by continuously secreting pathogenic antibodies, and they can contribute to flares of symptoms. As long-lived plasma cells are not sufficiently eliminated by current therapies, these findings are extremely relevant to the development of novel concepts for the treatment of autoimmune diseases. Thus, long-lived plasma cells appear to be a promising new therapeutic target. 相似文献
992.
Eriksen C Lindgren EN Olivecrona H Frisell J Stark B 《Journal of plastic surgery and hand surgery》2011,45(1):14-22
There have been many attempts to evaluate the shape, volume, and contour of breasts both before and after operation. To evaluate and compare results objectively in a reproducible, low-cost way is difficult. The aim of this study was to compare three-dimensional techniques with traditional methods in evaluating the volume and shape of breasts. Twelve patients with breast cancer were evaluated, 6 patients preoperatively and 6 patients postoperatively, using plastic cups, thermoplastic casts, magnetic resonance imaging (MRI), and three-dimensional imaging techniques. Thermoplastic casts and plastic cups measured better accordance with the volume of the operated breast than either the three-dimensional technique or MRI, which resulted in significantly higher values. The three-dimensional technique offered a new possibility to evaluate the shape of breasts objectively. 相似文献
993.
994.
995.
996.
997.
Nørgaard M Jensen AØ Engebjerg MC Farkas DK Thomsen RW Cha S Zhao S Sørensen HT 《Blood》2011,117(13):3514-3520
Few data exist on the long-term prognosis of patients with chronic primary chronic immune thrombocytopenia (ITP). We examined the risk of infections, hemorrhage resulting in hospitalization, hematologic malignancies, and total and cause-specific mortality among patients with ITP compared with the general population. We used population-based medical databases to identify 407 patients with primary chronic ITP diagnosed during 1996 to 2007 and 4069 general population members individually matched on age, sex, and comorbidity level. We used Cox regression analysis to estimate rate ratios (RRs) adjusted for age (≤ 60 or > 60 years), sex, calendar year, and level of comorbidity. The adjusted 1-year RR of infection was 4.5 (95% confidence interval [CI], 3.3-6.1) for patients with chronic ITP compared with the general population cohort. The adjusted RR decreased to 1.8 (95% CI, 1.3-2.5) for the second to fifth year of follow-up. The adjusted 5-year RR was 3.2 (95% CI, 1.2-9.0) for hospitalized intracranial hemorrhage, 4.4 (95% CI, 2.3-8.3) for other hospitalized hemorrhages, and 4.7 (95% CI, 1.7-12.7) for hematologic malignancy. The 5-year all-cause mortality RR was 2.3 (95% CI, 1.8-3.0). In summary, primary chronic ITP was associated with substantially increased long-term risk of infections, hemorrhagic episodes requiring hospitalization, hematologic malignancies, and mortality. 相似文献
998.
Patients with childhood leukemia surviving into adulthood have elevated risk of developing thyroid cancer, brain cancer, and non-Hodgkin lymphoma (NHL); these risks cannot automatically be extrapolated to patients surviving adult leukemia. We tested whether survivors of adult leukemia are at increased risk of developing thyroid cancer, brain cancer, and NHL. We included the entire adult Danish population (14 years of age or older), in a 28-year follow-up period from 1980 through 2007, composed of 6 542 639 persons; during this period, 18 834 developed adult leukemia, 4561 developed thyroid cancer, 13 362 developed brain cancer, and 15 967 developed NHL. In nested studies using Cox regression models on individual participant data, we found that, after adult leukemia, the multivariate adjusted hazard ratios were 4.9 (95% confidence interval [CI], 2.8-8.5) for thyroid cancer, 1.9 (95% CI, 1.2-3.1) for brain cancer, and 3.3 (95% CI, 2.5-4.4) for NHL. Corresponding hazard ratios after childhood leukemia were 10.4 (95% CI, 0.4-223) for thyroid cancer, 7.2 (95% CI, 2.0-26) for brain cancer, and 6.5 (95% CI, 0.4-110) for NHL. Patients with adult leukemia have excess risk of thyroid cancer, brain cancer, and NHL, similar to patients with childhood leukemia. 相似文献
999.
Maeng M Jensen LO Tilsted HH Kaltoft A Kelbaek H Abildgaard U Villadsen A Aarøe J Thayssen P Krusell LR Christiansen EH Bøtker HE Kristensen SD Ravkilde J Madsen M Sørensen HT Rasmussen K Thuesen L Lassen JF 《The American journal of cardiology》2011,(9):1232-1237
Diabetes is associated with an increased risk of major adverse cardiac events after percutaneous coronary intervention. We compared clinical outcomes in patients with and without diabetes mellitus treated with the second-generation Endeavor zotarolimus-eluting stent (ZES) or the first-generation Cypher Select+ sirolimus-eluting stent (SES). We randomized 2,332 patients to treatment with ZESs (n = 1,162, n = 169 diabetics) or SESs (n = 1,170, n = 168 diabetics) and followed them for 18 months. Randomization was stratified by presence/absence of diabetes. The primary end point was major adverse cardiac events defined as a composite of cardiac death, myocardial infarction, or target vessel revascularization. Secondary end points included these individual end points plus all-cause mortality and target lesion revascularization. In diabetic patients, use of ZES compared to SES was associated with an increased risk of major adverse cardiac events (18.3% vs 4.8%, hazard ratio 4.05, 95% confidence interval 1.86 to 8.82), myocardial infarction (4.7% vs 0.6%, hazard ratio 8.09, 95% confidence interval 1.01 to 64.7), target vessel revascularization (14.2% vs 3.0%, hazard ratio 4.99, 95% confidence interval 1.90 to 13.1), and target lesion revascularization (12.4% vs 1.2%, hazard ratio 11.0, 95% confidence interval 2.59 to 47.1). In patients without diabetes differences in absolute risk decrease were smaller but similarly favored SES. In conclusion, implantation of ZESs compared to SESs is associated with a considerable increased risk of adverse events in patients with diabetes at 18-month follow-up. 相似文献
1000.